Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.98 | N/A |
| PEG Ratio (TTM) | -6.76 | N/A |
| P/S Ratio (TTM) | 0.97 | N/A |
| P/B Ratio (TTM) | 2.73 | N/A |
| P/FCF Ratio (TTM) | 9.06 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.95 | N/A |
| Price to 5YR AVG FCF Ratio | 15.87 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.82% | N/A |
| ROE (TTM) | 15.21% | N/A |
| Net Profit Margin (TTM) | 5.11% | N/A |
| ROIC 5YR AVG | 12.59% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.61% | 20.71% | 10.86% |
| Revenue | 0.96% | 8.63% | 6.44% |
| Net Income | 3.32% | 20.71% | 10.54% |
| Cash Flow | 437.72% | 3.78% | 2.05% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.09 | N/A |
| Quick Ratio (TTM) | 0.75 | N/A |
| D/E Ratio (TTM) | 1.85 | N/A |
| Interest Coverage (TTM) | 3.53 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.21 | N/A |
| LTL to 5YR AVG FCF | 7.84 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.32% | N/A |